Stay updated on Pembrolizumab for Genomic Instability Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Study Plan header to Intervention/Treatment, while removing the older header spacing and bumping the revision version to v3.6.0. The recruitment status was changed to no longer recruiting, affecting enrollment availability.
    Difference
    0.4%
    Check dated 2026-06-14T07:38:58.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Updated the document revision from v3.5.4 to v3.5.5 in the Study Plan documents. This indicates a newer version of the protocol and SAP is now referenced on the page.
    Difference
    0.1%
    Check dated 2026-06-07T04:21:29.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.3 to v3.5.4, indicating a minor page update; no changes to the study data or eligibility criteria are indicated.
    Difference
    0.1%
    Check dated 2026-05-16T19:43:23.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number has been bumped from v3.5.2 to v3.5.3, reflecting a website release update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-25T06:24:30.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:57:22.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Study status updated to Active, not recruiting and results posted with related documentation (Results First Submitted/Posted) and dates. ORR outcome measure details are added to the Results section.
    Difference
    4%
    Check dated 2026-04-03T19:40:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.